Search - tctmd.com

Displaying 1 - 18 of 18

Sort: Relevancy | Date

News Daily News

AI-Supported Coaching Shows Promise for Improving Glycemic Control

L.A. McKeown

August 25, 2025

News Daily News

Cardiac Biomarkers Equally Apt to Rise in COVID-19, Influenza

Todd Neale

July 25, 2025

News Daily News

Medicaid Patients With Type 2 Diabetes Face Hurdles Getting Cardioprotective Meds

Michael O'Riordan

April 25, 2025

News Daily News

GLP-1 Drugs in Diabetes Don’t Raise Suicidality Risk, New Data Confirm

Caitlin E. Cox

February 26, 2025

News Daily News

Little Pre- and Postmarket Testing for Most Recalled CV Devices

Michael O'Riordan

September 16, 2024

News Daily News

ACC/AHA Clarify How Social Determinants of Health Impact CVD

Caitlin E. Cox

August 28, 2024

News Daily News

Semaglutide May Ease Tobacco Use, Study Suggests

Todd Neale

August 01, 2024

News Daily News

Efforts to Up PCSK9 Use Still Falling Short, Analysis Finds

L.A. McKeown

February 23, 2024

News Daily News

AHA/ACC Scientific Statement Supports Exercise Therapy in HFpEF

L.A. McKeown

March 27, 2023

News Daily News

Cardiac Biomarkers May Help Refine HF Risk Stratification, Progression

L.A. McKeown

February 17, 2023

News Daily News

HFrEF’s Financial Burden May Get Relief From Inflation Reduction Act

L.A. McKeown

January 13, 2023

News Daily News

Sky-high Cost of SGLT2i and GLP1 Agonists Deter First-line Use

L.A. McKeown

October 05, 2022

News Daily News

Comorbidities May Drive PAD Procedural Outcomes in Black Patients

L.A. McKeown

June 23, 2022

News Daily News

In the US, HF Prevalence—and Costs—Rising Steeply: HFSA Report

Michael O'Riordan

January 27, 2022

News Daily News

Stopping Statins Ups CVD and Mortality Risks in Pill-Burdened Seniors

Michael O'Riordan

June 16, 2021

News Daily News

AHA’s 2020 Top 10: ISCHEMIA, HCM, Early A-fib Intervention, and More

Shelley Wood

December 17, 2020

News Daily News

Most Secondary Prevention Patients Are Eligible for Multiple Drugs

Michael O'Riordan

January 03, 2020

News Daily News

FDA Tallies Cases of Fournier Gangrene in Patients Taking SGLT2 Inhibitors

Michael O'Riordan

May 08, 2019

Advertisement

AI-Supported Coaching Shows Promise for Improving Glycemic Control

Cardiac Biomarkers Equally Apt to Rise in COVID-19, Influenza

Medicaid Patients With Type 2 Diabetes Face Hurdles Getting Cardioprotective Meds

GLP-1 Drugs in Diabetes Don’t Raise Suicidality Risk, New Data Confirm

Little Pre- and Postmarket Testing for Most Recalled CV Devices

ACC/AHA Clarify How Social Determinants of Health Impact CVD

Semaglutide May Ease Tobacco Use, Study Suggests

Efforts to Up PCSK9 Use Still Falling Short, Analysis Finds

AHA/ACC Scientific Statement Supports Exercise Therapy in HFpEF

Cardiac Biomarkers May Help Refine HF Risk Stratification, Progression

HFrEF’s Financial Burden May Get Relief From Inflation Reduction Act

Sky-high Cost of SGLT2i and GLP1 Agonists Deter First-line Use

Comorbidities May Drive PAD Procedural Outcomes in Black Patients

In the US, HF Prevalence—and Costs—Rising Steeply: HFSA Report

Stopping Statins Ups CVD and Mortality Risks in Pill-Burdened Seniors

AHA’s 2020 Top 10: ISCHEMIA, HCM, Early A-fib Intervention, and More

Most Secondary Prevention Patients Are Eligible for Multiple Drugs

FDA Tallies Cases of Fournier Gangrene in Patients Taking SGLT2 Inhibitors

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content